immune response

Researchers combined tumor sequence, transcriptome, and patient immune cell response clues in their tumor-specific neoantigen detection and validation platform.

Using data from bone marrow registry participants, researchers found an HLA variant linked to symptom-free SARS-CoV-2 infection and better immune cell responses.

While four genetic mutations have been associated with the risk of developing PML, there is not consensus on which drugs merit preventive screening.